Ignite Creation Date:
2024-05-06 @ 5:58 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05494580
Status:
RECRUITING
Last Update Posted:
2023-04-11
First Post:
2022-07-26
Brief Title:
Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer
Sponsor:
Organization:
Sun Yat-sen University